Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,890,162 papers from all fields of science
Search
Sign In
Create Free Account
ASHAP protocol
Known as:
ARA-C/CDDP/DOX/MePRDL
, ASHAP
, Cisplatin/Cytarabine/Doxorubicin/Methylprednisolone
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
7 relations
Broader (2)
Antineoplastic Combined Chemotherapy Protocols
Methylprednisolone Hemisuccinate
Cisplatin
Cytarabine
Doxorubicin
Doxorubicin Hydrochloride
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Which regimen is better for stem cell mobilization of lymphoma patients?
S. Bozdağ
,
E. Tekgündüz
,
+4 authors
F. Altuntaş
Transfusion and Apheresis Science
2013
Corpus ID: 26268062
2011
2011
Dissolution and solubility of the arsenate – phosphate hydroxylapatite solid solution [ Ca 5 ( P x As 1 x O 4 ) 3 ( OH ) ] at 25 8
Xue-hong Zhang
,
Yinian Zhu
,
+5 authors
Liwei Xu
2011
Corpus ID: 54064950
Nine different members of the arsenate–phosphate hydroxylapatite solid solution [Ca5(PxAs1 xO4)3(OH)] were prepared and…
Expand
2008
2008
R-DHAP: A good small step, but not the journey's end
P. Mclaughlin
,
J. Vose
Leukemia and Lymphoma
2008
Corpus ID: 205699985
The DHAP regimen (dexamethasone, cytarabine, cisplatin) was first reported in 1988 as an effective lymphoma salvage regimen [1…
Expand
2008
2008
[Efficacy of alternating triple therapy on relapsed or refractory non-Hodgkin's lymphoma].
Hong Tian
,
Jie Chen
,
Ying Wu
,
Li-Li Li
Ai zheng = Aizheng = Chinese journal of cancer
2008
Corpus ID: 37072200
BACKGROUND & OBJECTIVE Treatment of relapsed or refractory non-Hodgkin's lymphoma (NHL) remains difficult. This study was to…
Expand
2007
2007
Rituximab plus ASHAP for the treatment of patients with relapsed or refractory aggressive non-Hodgkin’s lymphoma: a single-centre study of 20 patients
Semra Aydin
,
U. Dührsen
,
H. Nückel
Annals of Hematology
2007
Corpus ID: 407875
The anti-CD20 antibody rituximab improves the results of first-line therapy in aggressive non-Hodgkin’s lymphoma (NHL) of B cell…
Expand
2007
2007
Shap eMemor yAllo yActuato rwit hSimpl eAdaptiv eControl
Makoto Kumon
,
Ikuro Mizumoto
,
Zenta Iwai
,
Akifumi Indou
2007
Corpus ID: 111170451
This paper proposes a small Shape Memory Alloy actuator unit and its control algorithm. Since the unit contains a part to sense…
Expand
2004
2004
[Use of dexamethasone in treatment of high- and low-grade non-Hodgkin's lymphoma].
I. A. Alekseeva
,
A. Zaritskiĭ
,
N. Medvedeva
,
N. Mikhailova
,
L. S. Zubarovskaia
,
B. Afanas’ev
Voprosi onkologii
2004
Corpus ID: 9522285
Since it exerts a stronger antitumor action than predinisolone, dexamethasone was used for therapy of patients with non-Hodgkin's…
Expand
2000
2000
ASHAP – an effective salvage therapy for recurrent and refractory malignant lymphomas
M. Hänel
,
N. Kröger
,
+12 authors
A. Zander
Annals of Hematology
2000
Corpus ID: 6641239
Background: This study was performed to examine the efficacy and toxicity of the combination of adriamycin (ADR…
Expand
1999
1999
Factors influencing platelet recovery after autologous transplantation of G-CSF-mobilized peripheral blood stem/progenitor cells following myeloablative therapy in 50 heavily pretreated lymphoma…
H. Hassan
,
T. Hinz
,
N. Kroger
,
W. Zeller
,
A. Zander
Clinical and Laboratory Haematology
1999
Corpus ID: 25484618
Delayed platelet recovery following autologous PBPCs transplantation after myeloablative therapy remains an unresolved problem in…
Expand
1999
1999
Abbeys and monasteries
Derry Brabbs
1999
Corpus ID: 190381002
Introduction: establishment of early Christianity and first monasteries development monastic life decline and dissolution…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE